Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-01-04 @ 8:36 AM
Study NCT ID:
NCT02856568
Status:
WITHDRAWN
Last Update Posted:
2017-05-30
First Post:
2016-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-10
Completion Date Type:
ESTIMATED
First Submit Date:
2016-07-14
First Submit QC Date:
None
Study First Post Date:
2016-08-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-25
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL